ICD-10 Coding for Polysubstance Use(F19.1, F19.10, F19.10B)
Comprehensive guide on ICD-10 coding for polysubstance use, including documentation requirements, coding pitfalls, and billing considerations.
Complete code families applicable to Polysubstance Use
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| F19.10 | Unspecified polysubstance use, uncomplicated | Use when the provider explicitly states 'use' without abuse or dependence. |
|
| F19.20 | Polysubstance dependence, uncomplicated | Use when there is documented dependence, such as tolerance or withdrawal. |
|
| F19.24 | Polysubstance dependence with withdrawal | Use when withdrawal symptoms are documented with standardized scales. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutPolysubstance Use
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Polysubstance Use.
Vague documentation of 'polysubstance use'
Impact
Clinical: Inadequate treatment planning, Regulatory: Potential audit issues, Financial: Underpayment due to incorrect coding
Mitigation
Specify each substance, Document usage patterns
Using F19.10 when specific substances are documented
Impact
Reimbursement: Potential underpayment due to incorrect DRG assignment, Compliance: Non-compliance with coding guidelines, Data Quality: Inaccurate clinical data representation
Mitigation
Code F19.20 or F19.24 with specific substance codes
Incorrect coding of polysubstance use
Impact
Failure to document specific substances can lead to audit findings.
Mitigation
Ensure all substances are documented and coded.